Clinical Trial Update: Towards Cure Via Only Ultra-short ICB in CSCC [Phase 2]

View source ↗

Summary

The Netherlands Cancer Institute is conducting a Phase 2 trial in cutaneous squamous cell carcinoma using ultra-short immune checkpoint blockade and is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma
• Cutaneous Squamous Cell Carcinoma of the Head and Neck

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Cutaneous Squamous Cell Carcinoma (CSCC), Cutaneous Squamous Cell Cancer | Phase 2 | Status: RECRUITING